Debjit Chattopadhyay
Stock Analyst at Guggenheim
(4.81)
# 505
Out of 4,698 analysts
673
Total ratings
49.9%
Success rate
18.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debjit Chattopadhyay
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SCTX Scribe Therapeutics | Initiated Coverage: Buy | $50 | $30.81 | +62.28% | 1 | Aug 18, 2026 | |
| SPRB Spruce Biosciences | Maintained: Buy | $123 → $104 | $57.71 | +80.21% | 2 | Aug 17, 2026 | |
| NGNE Neurogene | Maintained: Buy | $69 → $81 | $37.61 | +115.37% | 4 | Aug 11, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $43 → $35 | $14.85 | +135.69% | 6 | Aug 3, 2026 | |
| IONS Ionis Pharmaceuticals | Maintained: Buy | $106 → $89 | $58.13 | +53.11% | 13 | Jul 21, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Maintained: Buy | $31.82 | $12.53 | +153.98% | 4 | Jul 9, 2026 | |
| EWTX Edgewise Therapeutics | Maintained: Buy | $51 | $41.95 | +21.57% | 6 | Jul 6, 2026 | |
| RZLT Rezolute | Rated: Buy | $6 → $11 | $4.54 | +142.29% | 5 | Jun 15, 2026 | |
| BNTC Benitec Biopharma | Downgraded: Hold | n/a | $12.44 | - | 2 | Jun 10, 2026 | |
| NTLA Intellia Therapeutics | Rated: Hold | n/a | $12.68 | - | 7 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.75 | - | 6 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.18 | +120.13% | 4 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $17 | $7.17 | +137.10% | 3 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $4.60 | +247.83% | 1 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $3.38 | +550.89% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $7.37 | +157.80% | 16 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $25.85 | +74.08% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $284 | $371.47 | -23.55% | 8 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $10.42 | +149.52% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $46 → $58 | $25.87 | +124.20% | 4 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $39 | $35.66 | +9.37% | 2 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $4.84 | +519.83% | 1 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $95 | $44.86 | +111.77% | 64 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $22.99 | -4.31% | 101 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $5 | $3.71 | n/a | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 → $106 | $66.43 | n/a | 8 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $450 → $546 | $557.96 | n/a | 7 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $55 | $29.46 | n/a | 5 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $50 | $24.95 | n/a | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $56.49 | n/a | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $264.50 | n/a | 3 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $24 | $5.57 | n/a | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.08 | n/a | 1 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $14 → $16 | $0.1662 | n/a | 10 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $20.54 | n/a | 14 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $4.70 | n/a | 19 | Sep 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $29.99 | n/a | 8 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 25.00 | CHF 3.50 | n/a | 7 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $270 → $123 | $29.02 | n/a | 19 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $30 | $12.80 | n/a | 20 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $29.92 | n/a | 19 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $2.29 | n/a | 20 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $2.42 | n/a | 4 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 | $29.90 | n/a | 10 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $1.98 | n/a | 6 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $4.24 | n/a | 5 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $4.25 | n/a | 45 | Jul 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 → $26 | $76.37 | n/a | 50 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 | $17.13 | n/a | 15 | Dec 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $33.13 | n/a | 9 | Aug 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $7 | $112.80 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $1.5 | $0.7131 | n/a | 5 | Oct 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7.5 → $10 | $17.46 | n/a | 23 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $63 | $71.40 | n/a | 19 | Oct 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.2786 | n/a | 7 | Aug 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $16 | $15.56 | n/a | 13 | Aug 14, 2015 |
Scribe Therapeutics
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $30.81
Upside: +62.28%
Spruce Biosciences
Aug 17, 2026
Maintained: Buy
Price Target: $123 → $104
Current: $57.71
Upside: +80.21%
Neurogene
Aug 11, 2026
Maintained: Buy
Price Target: $69 → $81
Current: $37.61
Upside: +115.37%
Ultragenyx Pharmaceutical
Aug 3, 2026
Maintained: Buy
Price Target: $43 → $35
Current: $14.85
Upside: +135.69%
Ionis Pharmaceuticals
Jul 21, 2026
Maintained: Buy
Price Target: $106 → $89
Current: $58.13
Upside: +53.11%
Satellos Bioscience Inc.
Jul 9, 2026
Maintained: Buy
Price Target: $31.82
Current: $12.53
Upside: +153.98%
Edgewise Therapeutics
Jul 6, 2026
Maintained: Buy
Price Target: $51
Current: $41.95
Upside: +21.57%
Rezolute
Jun 15, 2026
Rated: Buy
Price Target: $6 → $11
Current: $4.54
Upside: +142.29%
Benitec Biopharma
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $12.44
Upside: -
Intellia Therapeutics
Jun 10, 2026
Rated: Hold
Price Target: n/a
Current: $12.68
Upside: -
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $4.75
Upside: -
Jun 8, 2026
Reiterated: Buy
Price Target: $7
Current: $3.18
Upside: +120.13%
Jun 5, 2026
Maintained: Buy
Price Target: $20 → $17
Current: $7.17
Upside: +137.10%
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $4.60
Upside: +247.83%
Jun 2, 2026
Maintained: Buy
Price Target: $22
Current: $3.38
Upside: +550.89%
May 28, 2026
Maintained: Buy
Price Target: $19
Current: $7.37
Upside: +157.80%
May 7, 2026
Maintained: Buy
Price Target: $45
Current: $25.85
Upside: +74.08%
May 4, 2026
Reiterated: Buy
Price Target: $284
Current: $371.47
Upside: -23.55%
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $10.42
Upside: +149.52%
Mar 4, 2026
Rated: Buy
Price Target: $46 → $58
Current: $25.87
Upside: +124.20%
Dec 3, 2025
Maintained: Buy
Price Target: $32 → $39
Current: $35.66
Upside: +9.37%
Oct 15, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $4.84
Upside: +519.83%
Sep 24, 2025
Maintained: Buy
Price Target: $28 → $95
Current: $44.86
Upside: +111.77%
Sep 15, 2025
Reiterated: Buy
Price Target: $22
Current: $22.99
Upside: -4.31%
Aug 13, 2025
Maintained: Buy
Price Target: $20 → $5
Current: $3.71
Upside: n/a
Aug 6, 2025
Maintained: Buy
Price Target: $110 → $106
Current: $66.43
Upside: n/a
Aug 6, 2025
Maintained: Buy
Price Target: $450 → $546
Current: $557.96
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $78 → $55
Current: $29.46
Upside: n/a
Aug 14, 2024
Maintained: Buy
Price Target: $45 → $50
Current: $24.95
Upside: n/a
Jun 28, 2024
Rated: Hold
Price Target: n/a
Current: $56.49
Upside: n/a
Jun 27, 2022
Downgraded: Hold
Price Target: n/a
Current: $264.50
Upside: n/a
Apr 5, 2022
Maintained: Buy
Price Target: $28 → $24
Current: $5.57
Upside: n/a
Mar 17, 2021
Initiated Coverage: Hold
Price Target: n/a
Current: $3.08
Upside: n/a
Jan 6, 2021
Initiated Coverage: Hold
Price Target: $14 → $16
Current: $0.1662
Upside: n/a
Sep 3, 2020
Reiterated: Buy
Price Target: $17
Current: $20.54
Upside: n/a
Sep 1, 2020
Maintained: Buy
Price Target: $20
Current: $4.70
Upside: n/a
Aug 31, 2020
Reiterated: Buy
Price Target: $30
Current: $29.99
Upside: n/a
Aug 28, 2020
Reiterated: Buy
Price Target: CHF 25.00
Current: CHF 3.50
Upside: n/a
Aug 24, 2020
Downgraded: Hold
Price Target: $270 → $123
Current: $29.02
Upside: n/a
Aug 11, 2020
Maintained: Buy
Price Target: $36 → $30
Current: $12.80
Upside: n/a
Aug 10, 2020
Reiterated: Hold
Price Target: $13
Current: $29.92
Upside: n/a
Aug 7, 2020
Reiterated: Buy
Price Target: $24
Current: $2.29
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $42
Current: $2.42
Upside: n/a
Aug 6, 2020
Maintained: Buy
Price Target: $54
Current: $29.90
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $49
Current: $1.98
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $25
Current: $4.24
Upside: n/a
Jul 31, 2020
Reiterated: Buy
Price Target: $40
Current: $4.25
Upside: n/a
May 12, 2020
Reiterated: Hold
Price Target: $32 → $26
Current: $76.37
Upside: n/a
Dec 18, 2019
Maintained: Buy
Price Target: $2
Current: $17.13
Upside: n/a
Aug 1, 2017
Maintained: Hold
Price Target: n/a
Current: $33.13
Upside: n/a
Dec 20, 2016
Initiated Coverage: Sell
Price Target: $7
Current: $112.80
Upside: n/a
Oct 20, 2016
Maintained: Hold
Price Target: $9 → $1.5
Current: $0.7131
Upside: n/a
Oct 26, 2015
Initiated Coverage: Buy
Price Target: $7.5 → $10
Current: $17.46
Upside: n/a
Oct 16, 2015
Maintained: Hold
Price Target: $63
Current: $71.40
Upside: n/a
Aug 16, 2015
Maintained: Buy
Price Target: $4
Current: $0.2786
Upside: n/a
Aug 14, 2015
Reiterated: Buy
Price Target: $10 → $16
Current: $15.56
Upside: n/a